STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could be rising, in part due to the spread of the more transmissible variants (Delta, etc.), but the approved vaccines seem to be containing the spread, and more importantly, limiting the severity of the disease (for a vaccinated individual). The AP published…
Energy positive returns 6 consecutive months. Stick with Epicenter in 2H2021.
A financial market resource for the every-day investor and trader.
-
The Charts, The Tables, The Quants, The Cycles
Seth Golden, , Research Reports, 1
IT’S OFFICIAL! The S&P 500 has achieved our year-end price target of 4,750, formerly disseminated within our weekly Research...
-
Weekly State of the Market: Market And The Economy
Seth Golden, , Research Reports, 0
“At the bottom, stocks will be cheap and no one will care.” ~Bob Farrell “When it’s time to buy,...
-
Corrections and Convictions
Seth Golden, , Research Reports, 0
Somewhere’s in the recess of my childhood memories I can now hear Count Dracula from Sesame Street saying, “1...
-
BofA GPS: Global Proprietary Signals The weight of the evidence
Seth Golden, , Research Reports, 0
Key takeaways Soft landing (47% Bearish signals vs 58% in Sep-22), but still below-trend outlook; mfg take-off unlikely before...
-
Weekly State of The Market: With Tapering, New Highs Hard to Achieve
Seth Golden, , Research Reports, 0
Thank you for joining us on this journey through the markets in 2021. To review the latest State of...
-
-
Treachery in Early 2022? Will It Last?
Seth Golden, , Research Reports, 0
After 3 consecutive years of double-digit returns for investors who stayed the course, through the ups and downs, downs...
-
February Found Little Upside Resistance, But Will March Find Consolidation?
Seth Golden, , Research Reports, 0
Good weekend Finom Group traders/investors! While this is our off-reporting weekend (no proprietary Research Report), we aim to deliver...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00